38 Global Improvement and Patient Satisfaction: Results from a Long-term, Open-label, Rollover Study of Valbenazine in Tardive Dyskinesia

MLA

Cherian Verghese, et al. “38 Global Improvement and Patient Satisfaction: Results from a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia.” CNS Spectrums, vol. 24, Feb. 2019, pp. 195–96. EBSCOhost, https://doi.org/10.1017/s1092852919000312.

APA

Cherian Verghese, Roland Jimenez, Chuck Yonan, Scott Siegert, Joshua Burke, Khody Farahmand, Jean-Pierre Lindenmayer, & Stephen R. Marder. (2019). 38 Global Improvement and Patient Satisfaction: Results from a Long-term, Open-label, Rollover Study of Valbenazine in Tardive Dyskinesia. CNS Spectrums, 24, 195–196. https://doi.org/10.1017/s1092852919000312

Chicago

Cherian Verghese, Roland Jimenez, Chuck Yonan, Scott Siegert, Joshua Burke, Khody Farahmand, Jean-Pierre Lindenmayer, and Stephen R. Marder. 2019. “38 Global Improvement and Patient Satisfaction: Results from a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia.” CNS Spectrums 24 (February): 195–96. doi:10.1017/s1092852919000312.